| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.33B | +29.9% |
| R&D Expense | $4.3M | +258.3% |
| SG&A Expense | $459.5M | +39.5% |
| Operating Income | $247.0M | +115.2% |
| Interest Expense | $9.3M | -71.0% |
| Pre-tax Income | -$1.6M | -101.3% |
| Income Tax | -$296.1M | -8608.8% |
| Net Income | $229.6M | +166.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.21B | +166.4% |
| Accounts Receivable | $348.7M | +35.8% |
| Inventory | $8.9M | +161.8% |
| Current Assets | $1.91B | +65.6% |
| Total Assets | $5.04B | +48.8% |
| Current Liabilities | $1.38B | +95.9% |
| Long-term Debt | $2.84B | +60.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $500.3M | +28.8% |
| Capital Expenditures | $7.1M | -48.2% |
| Investing Cash Flow | -$691.1M | -128.9% |
| Financing Cash Flow | $929.2M | +710.5% |
| Free Cash Flow | $493.2M | +31.7% |
| Total Liabilities |
| $4.02B |
| +59.7% |
| Stockholders' Equity | $806.6M | +23.5% |